ӢQ:3-O-FeruloylquinicacidӢͬx~:3-O-Feruloylquinicacid;5-Feruoylquinicacid;(1S,3S,4S,5S)-1,3,4-trihydroxy-5-{[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}cyclohexanecarboxylicacid
؛̖(ho) | Ҏ(gu) | (sh) | r(ji) |
---|---|---|---|
Q-0099009 | 100mg |
1
|
ԃr(ji) |
Q-0099009 | 250mg |
1
|
ԃr(ji) |
Q-0099009 | 500mg |
1
|
ԃr(ji) |
Q-0099009 | 1g |
1
|
ԃr(ji) |
Q-0099009 | 5g |
1
|
ԃr(ji) |

3-O-κQ
3-O-κ
Ӣ (1S,3S,4S,5S)-1,3,4-trihydroxy-5-[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxycyclohexane-1-carboxylic acid
Ąe 3-O-κ
ܶ 1.53g/cm3
c(din) 629.4ºC at 760 mmHg
c(din) 196-197 ºC
ʽ C17H20O9
368.33500
Wc(din) 228.6ºC
|(zh) 368.11100
PSA 153.75000
1.05E-16mmHg at 25°C
;
B(ti)w/ĩ/Һ
a(chn)أ
(ch)r(sh)g1
棺
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖(ho) | N/A |
N/A | |
(ch)l | -20ܹⱣ |
(ch)r(sh)g | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ Danoprevir;ITMN-191; R7227; RO5190591; RG7227CAS850876-88-9 ^N/A N/A Hʹ
-
pgӹٷƼ˾ṩ DalfopristinCAS112362-50-2 ^N/A N/A Hʹ
-
ӢQ:1,2:4,5-DI-O-ISOPROPYLIDENE-BETA-D-ERYTHRO-2,3-HEXODIULO-2,6-PYRANOSEӢͬx~:1,2:4,5-DI-O-ISOPROPYLIDEN-BETA-ERYTHRO-2,3-HEXODIULO-2,6-PYRANOSE
-
ӢQ:2,5-DibromoterephthalicaciddiethylesterӢͬx~:2,5-Dibromoterephthalicaciddiethylester;Diethyl2,5-dibromoterephthalate;Diethyl1,4-dibromo-2,5-benzenedicarboxylate